Here’s what you should know:
1. The revolving loan will provide Exact Sciences the money on a 24-month secured revolving credit facility. The loan matures in December 2019.
2. The non-revolving loan matures in December 2022. Exact Sciences will pay interest equal to the sum of the one-month Libor rate, with an additional 2.25 percent.
3. The company will use both loans to finance its recently announced expansion project. To secure both loans, Exact Sciences had to pledge $16.4 million of its own capital.
More articles on gastroenterology:
GI leader to know: Dr. Anil Sharma of Gastroenterology Group of Rochester
82% of early-onset CRC cases misdiagnosed — 10 study insights
Takeda, TiGenix’s complex perianal fistulas treatment receives 1st ever positive EMA opinion — 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
